News | May 24, 2023
Biocon posts Q4 FY23 consolidated PAT at Rs. 313.2 Cr
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience
The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
